Schonfeld Strategic Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-69,755
| Closed | -$428K | – | 2195 |
|
|
2025
Q4 | $428K | Sell |
69,755
-598,072
| -90% | -$6.46M | ﹤0.01% | 1453 |
|
|
2025
Q3 | $12.3M | Sell |
667,827
-116,580
| -15% | -$1.87M | 0.09% | 288 |
|
|
2025
Q2 | $10.2M | Sell |
784,407
-41,359
| -5% | -$489K | 0.08% | 333 |
|
|
2025
Q1 | $8.74M | Sell |
825,766
-23,315
| -3% | -$370K | 0.06% | 365 |
|
|
2024
Q4 | $14.4M | Buy |
849,081
+479,482
| +130% | +$9.03M | 0.09% | 215 |
|
|
2024
Q3 | $8.58M | Buy |
369,599
+86,179
| +30% | +$1.84M | 0.07% | 343 |
|
|
2024
Q2 | $6.9M | Sell |
283,420
-63,074
| -18% | -$1.91M | 0.05% | 466 |
|
|
2024
Q1 | $11.7M | Sell |
346,494
-54,987
| -14% | -$1.95M | 0.09% | 322 |
|
|
2023
Q4 | $12.7M | Buy |
401,481
+294,325
| +275% | +$7M | 0.1% | 280 |
|
|
2023
Q3 | $2.74M | Buy |
+107,156
| New | +$3.3M | 0.03% | 723 |
|
|
2022
Q4 | – | Sell |
-41,567
| Closed | -$616K | – | 2573 |
|
|
2022
Q3 | $616K | Sell |
41,567
-226,030
| -84% | -$3.79M | 0.01% | 1598 |
|
|
2022
Q2 | $4.21M | Buy |
267,597
+191,501
| +252% | +$3.76M | 0.04% | 520 |
|
|
2022
Q1 | $2.05M | Buy |
76,096
+20,348
| +36% | +$519K | 0.02% | 729 |
|
|
2021
Q4 | $2.06M | Sell |
55,748
-44,879
| -45% | -$1.83M | 0.02% | 694 |
|
|
2021
Q3 | $4.81M | Buy |
100,627
+77,095
| +328% | +$3.45M | 0.05% | 450 |
|
|
2021
Q2 | $796K | Buy |
23,532
+4,324
| +23% | +$146K | 0.01% | 1004 |
|
|
2021
Q1 | $793K | Sell |
19,208
-16,060
| -46% | -$957K | 0.01% | 980 |
|
|
2020
Q4 | $1.53M | Sell |
35,268
-129,102
| -79% | -$8.74M | 0.02% | 677 |
|
|
2020
Q3 | $7.05M | Buy |
164,370
+144,933
| +746% | +$7.19M | 0.14% | 214 |
|
|
2020
Q2 | $908K | Buy |
+19,437
| New | +$670K | 0.03% | 621 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
